Director/PDMR Shareholding

Amlin Plc FOR IMMEDIATE RELEASE AMLIN PLC ('Amlin') RIGHTS ISSUE DIRECTORS' DEALINGS In accordance with the Directors' intentions stated in the Prospectus relating to the rights issue of the Company's shares announced on 1 November 2005 ('Rights Issue'), and as required by Section 324 of the Companies Act 1985 and Disclosure Rule 3.1.2R, Amlin announces that, in connection with the Rights Issue, the following sales of Amlin nil paid New Ordinary Shares of 25p each ('Nil Paid Rights') have been made by Directors and Persons Discharging Managerial Responsibility ('PDMRs'): Director/PDMR Nil Paid Date of Price Current Current Rights sale per shareholding shareholding sold Nil Paid Right Number % Directors --------------------------- B D Carpenter (and spouse) 162,764 3/11/05 48p 677,924 0.169 R A Hextall 34,203 3/11/05 48p 136,981 0.034 A W Holt (and spouse) 569,053 3/11/05 48p 2,522,518 0.630 C E L Philipps 62,174 3/11/05 48p 255,488 0.064 Lord Stewartby 10,707 8/11/05 51.5p 46,054 0.011 PDMRs --------------------------- S C W Beale 64,556 4/11/05 48p 264,084 0.066 J le T Illingworth 44,156 3/11/05 48p 176,841 0.044 The above mentioned Directors and PDMRs intend to subscribe for the following balances of New Ordinary Shares in the Rights Issue following their sales of Nil Paid Rights: Director/PDMR New Ordinary Shares intended to be subscribed in Rights Issue ---------------------------------- B D Carpenter (and spouse) 46,428 R A Hextall 9,381 A W Holt (and spouse) 233,566 C E L Philipps (excluding Nil Paid Rights arising in PEP) 17,246 Lord Stewartby 3,946 PDMRs ---------------------------------- S C W Beale 19,470 J le T Illingworth 12,110 Certain terms used in this announcement are defined and have the same meaning in the Rights Issue Prospectus. Enquiries: Charles Pender 020 7746 1000 Secretary Amlin plc 10 November 2005 Hoare Govett Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as sponsor, underwriter, broker and joint financial adviser to Amlin in connection with the Rights Issue and the listing of the New Ordinary Shares on the Official List and their admission to trading on the London Stock Exchange's market for listed securities and will not be responsible to anyone other than Amlin for providing the protections afforded to clients of Hoare Govett Limited or for providing advice in relation to the Rights Issue, proposed listing or admission to trading or contents of this announcement or any other matters referred to in this announcement. Lexicon Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as joint financial adviser to Amlin in connection with the Rights Issue and the listing of the New Ordinary Shares on the Official List and their admission to trading on the London Stock Exchange's market for listed securities and will not be responsible to anyone other than Amlin for providing the protections afforded to customers of Lexicon Partners Limited or for providing advice in relation to the Rights Issue, proposed listing or admission to trading or contents of this announcement or any other matters referred to in this announcement. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions. No offer, invitation or inducement to acquire shares or other securities in Amlin is being made by or in connection with this announcement. Any offer, invitation or inducement to acquire shares in Amlin will be made solely by means of the prospectus, published on 2 November 2005, as updated by any supplementary prospectus, and any decision to keep, buy or sell shares in Amlin should be made solely on the basis of the information contained in such document(s). This announcement is not for distribution or transmission, directly or indirectly, in or into the United States, Canada, Australia, Japan, New Zealand or the Republic of South Africa and does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for or buy and any securities ('Securities'), nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the Securities referred to in this announcement in any jurisdiction in contravention of applicable law. The Securities have not been and will not be registered under the US Securities Act of 1933, as amended (the 'Securities Act') and may not be offered or sold in the United States unless registered under the Securities Act or an exemption from such registration is available. No public offering of Securities of Amlin is being made in the United States.
UK 100

Latest directors dealings